Critical Path Institute
Critical Path Institute (C-Path) is an independent, nonprofit organization established in 2005 as a public and private partnership. C-Path’s mission is to catalyze the development of new approaches that advance medical innovation and regulatory science, accelerating the path to a healthier world. An international leader in forming collaborations, C-Path has established numerous global consortia that currently include more than 1,600 scientists from government and regulatory agencies, academia, patient organizations, disease foundations, and dozens of pharmaceutical and biotech companies. C-Path US is headquartered in Tucson, Arizona and C-Path, Ltd. EU is headquartered in Dublin, Ireland, with additional staff in multiple other locations. For more information, visit c-path.org and c-path.eu.- 2:08
- Ай бұрын
I am BIO Podcast with Kristen Swingle, President & Chief Operating Officer Critical Path Inst...
- 3:51
- Ай бұрын
Critical Path Institute Leads Collaborations
- 1:00:19
- Ай бұрын
The Use and Development of DHTs with Patient Advocacy Groups
- 55:00
- 2 ай бұрын
Webinar: TRxA BioBRIDGe Awards
- 41:06
- 2 ай бұрын
C-Path Roundtable: C-Path, Help4HD Unite to Discuss Advancements in Huntington's Disease Tre...
- 33:26
- 2 ай бұрын
Clinical Outcome Assessment - Initial Public Discussion
- 2:13
- 2 ай бұрын
How Individuals and Organizations Can Support TRxA?
- 56:42
- 4 ай бұрын
Improving Data Collection for Rare Epilepsies: Case example from the TSC Natural History Database
- 2:14:29
- 4 ай бұрын
Rare Neurodegenerative Disease Efforts Under the ACT for ALS
- 1:34
- 4 ай бұрын
C-Path CEO Klaus Romero Guitar Shred for Show Your Stripes Campaign on Rare Disease Day 2024
- 1:09
- 4 ай бұрын
Critical Path Institute Expands Data Analytics to Mitochondrial and Inherited Metabolic Diseases
- 3:24
- 4 ай бұрын
CIVM Workshop 2023 Day 2: Opening Remarks
- 40:24
- 5 ай бұрын
CIVM 2023 Day 2 : Breakout Sessions - Drafting a Qualification Utilizing Sessions 1, 2, and 3
- 15:02
- 5 ай бұрын
CIVM Workshop Day One: Perspective on Translating New Drug Development Tools into Regulatory Use
- 55:53
- 5 ай бұрын
SBS Day 2 - Session IV: Clinical Trial Design Considerations
- 1:09:28
- 5 ай бұрын
SBS Day 2 - Panel IV-b Considerations for Clinical Trial Design Optimization in Neonates and T1D
- 1:10:15
- 5 ай бұрын
SBS Day 2 - Session III-b: Disease Prevention in Lysosomal Diseases
- 22:01
- 5 ай бұрын
SBS Day 2 - Disease Prevention in T1D and Neonates Panel
- 16:56
- 5 ай бұрын
SBS Day 2 - Session III Disease Prevention
- 59:39
- 5 ай бұрын
Understanding Disease Progression Models: What are They, Why are They Useful, & How Are They ...
- 1:01:55
- 5 ай бұрын
Пікірлер